The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1270 articles
Amazon and Walmart are racing to dominate GLP-1 medications like Eli Lilly's new oral Foundayo, but their strategies extend far beyond filling prescriptions for weight loss. With same-day delivery, telehealth, and integrated services, they're building 'continuous care commerce' platforms. This shift promises ongoing patient support for long-term therapy success.
Peptides are sweeping social media as injectables for clear skin, muscle gains, and fat loss, but a regulatory crackdown signals a war on unapproved versions. With FDA seizures, RFK Jr.'s advocacy, and black market persistence, what does this mean for beauty's future? Uncover the murky truths behind the hype.
A groundbreaking study reveals tirzepatide outperforms semaglutide and insulin degludec in speeding up blood sugar control and weight loss for type 2 diabetes patients. Participants on tirzepatide hit HbA1c targets below 7% in just eight weeks, compared to twelve weeks for alternatives. These faster results could boost long-term adherence and health outcomes.
Serena Williams' 2026 Super Bowl ad spotlighted her GLP-1 weight-loss journey, fueling massive online searches for drugs like Ozempic and Wegovy. With ads bombarding daily life and insurance often falling short, a booming online market offers cheaper options—but at what risk? Here's what you need to know to safely buy GLP-1 drugs online.
In 2026, the gut reset era is transforming weight loss by linking it inseparably to digestive health and metabolism. No longer isolated goals, bloating, slow metabolism, and weight gain are addressed holistically for lasting results. From microbiome breakthroughs to personalized tech tools, this integrated approach promises better outcomes.
A disciplined 35-year-old film actor walked into a Mumbai clinic with Type 2 diabetes after two years of unregulated peptide injections for a muscular physique. Recommended by his gym trainer, drugs like MOTS-c and tamoxifen wreaked havoc, causing insulin resistance. Experts reveal the growing misuse in fitness circles and how to spot the risks.
Institutional investors have sidelined climate change in ESG priorities, favoring health tech fueled by Ozempic and GLP-1 drugs. A Berenberg Bank survey of 200 investors ranks health first as climate slips to fifth. Yet, climate change poses severe health threats from heatwaves to vector-borne diseases—why this mania could backfire.
Content creator Aishwarya Mohanraj's candid video about dropping from 74kg to 52kg in six months on Mounjaro has spotlighted the injectable drug. Amid PCOS and hypothyroidism challenges, her story shifts focus from Ozempic hype. But experts warn: pair it with lifestyle changes or risk weight regain.
The hype around Mounjaro's weight loss results is real, but so is 'Mounjaro face'—sharper yet tired-looking facial changes from rapid fat loss. Dermatologists and surgeons report more patients with hollowed cheeks and sagging skin seeking help. Experts reveal why it occurs and essential prevention strategies focusing on nutrition and skincare.
